H2-Calponin Modulation via Protease Degradation for Cancer Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective solutions for controlling the activity levels of h2-calponin, a protein influencing cell migration and proliferation, which are critical for various medical conditions such as cancer, atherosclerosis, and wound healing, and for diagnosing diseases like myeloid leukemia.
Innovation Solution
The development of methods to alter h2-calponin activity levels by expressing variants or using modulators that inhibit or enhance its activity, including protease-induced degradation and specific antibodies, to regulate cell proliferation and migration in different cell types.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If h2-calponin activity is increased to inhibit cell proliferation, then cancer growth is suppressed, but wound healing and tissue repair are impaired
Solution Approach 1:
The patent employs dynamic control of h2-calponin activity through inducible expression systems and transient modulation approaches, allowing the protein activity to be adjusted over time rather than maintained at constant high levels. This enables cancer suppression when needed while permitting normal physiological processes like wound healing to proceed when h2-calponin activity is reduced or temporarily inhibited.
Solution Approach 2:
The patent applies h2-calponin modulation selectively to specific tissue locations or cell types affected by cancer, rather than systemically throughout the body. This localized approach allows cancer suppression in target tissues while minimizing interference with wound healing and tissue repair processes in other regions where h2-calponin activity remains normal.
2Reliability
If h2-calponin expression is altered to control cell migration, then disease progression is slowed, but physiological functions are disrupted
Solution Approach 1:
The patent utilizes periodic or cyclic modulation of h2-calponin expression levels, alternating between periods of elevated expression for disease control and periods of reduced expression to allow normal physiological functions. This rhythmic approach maintains disease suppression while preserving essential physiological adaptability.
Solution Approach 2:
The patent changes the expression parameters of h2-calponin (timing, duration, intensity) rather than permanently altering the protein's fundamental properties. This allows flexible adjustment of h2-calponin activity to achieve disease control while maintaining the ability to restore normal physiological function when expression parameters are modified.
3Reliability
If h2-calponin activity is modulated using protease-induced degradation, then cell proliferation is controlled, but protein stability is reduced
Solution Approach 1:
The patent introduces protease-sensitive linkers or degradation tags as intermediary elements that connect h2-calponin to controlled degradation mechanisms. These intermediaries allow regulated protein breakdown through protease activation only under specific conditions, providing proliferation control while maintaining protein stability during normal physiological states when the degradation pathway is not activated.
Data Source
AI summary
The invention provides methods for identifying modulators of mammalian, e.g., human, h2-calponin, the calponin isoform of relatively neutral pI. H2-calponin exerts an effect on the migration and proliferation of a variety of muscle (smooth muscle) and non-muscle cells and is an actin filament-associated regulatory protein influencing the structure of the actin cytoskeleton. Modulators of the activity levels of this protein are useful in preventing, ameliorating, or treating a variety of diseases, disorders or conditions characterized by aberrant cell migration and/or cell proliferation.